Global Metabotropic Glutamate Receptor (MRG) Market Insights, Research, Forecast to 2025

Published On: Aug 2019

Format: PDF

Publisher: QY Research

Pages: 111

Report ID: 348313

The metabotropic glutamate receptors are a type of glutamate receptor that are active through an indirect metabotropic process.
The global Metabotropic Glutamate Receptor (MRG) market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Metabotropic Glutamate Receptor (MRG) market based on company, product type, end user and key regions.

This report studies the global market size of Metabotropic Glutamate Receptor (MRG) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Metabotropic Glutamate Receptor (MRG) in these regions.
This research report categorizes the global Metabotropic Glutamate Receptor (MRG) market by top players/brands, region, type and end user. This report also studies the global Metabotropic Glutamate Receptor (MRG) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Addex Therapeutics (Switzerland)
Domain Therapeutics (France)
Medgenics (USA)
Prexton Therapeutics (Switzerland)
Taisho Pharmaceutical Holding (Japan)

Market size by Product
mGluR2
mGluR4
mGluR5
Market size by End User
Meningitis
Septicemia
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Metabotropic Glutamate Receptor (MRG) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Metabotropic Glutamate Receptor (MRG) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Metabotropic Glutamate Receptor (MRG) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Metabotropic Glutamate Receptor (MRG) submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Metabotropic Glutamate Receptor (MRG) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Metabotropic Glutamate Receptor (MRG) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Metabotropic Glutamate Receptor (MRG) Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Metabotropic Glutamate Receptor (MRG) Market Size Growth Rate by Product
1.4.2 mGluR2
1.4.3 mGluR4
1.4.4 mGluR5
1.5 Market by End User
1.5.1 Global Metabotropic Glutamate Receptor (MRG) Market Size Growth Rate by End User
1.5.2 Meningitis
1.5.3 Septicemia
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Metabotropic Glutamate Receptor (MRG) Market Size
2.1.1 Global Metabotropic Glutamate Receptor (MRG) Revenue 2014-2025
2.1.2 Global Metabotropic Glutamate Receptor (MRG) Sales 2014-2025
2.2 Metabotropic Glutamate Receptor (MRG) Growth Rate by Regions
2.2.1 Global Metabotropic Glutamate Receptor (MRG) Sales by Regions
2.2.2 Global Metabotropic Glutamate Receptor (MRG) Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Metabotropic Glutamate Receptor (MRG) Sales by Manufacturers
3.1.1 Metabotropic Glutamate Receptor (MRG) Sales by Manufacturers
3.1.2 Metabotropic Glutamate Receptor (MRG) Sales Market Share by Manufacturers
3.1.3 Global Metabotropic Glutamate Receptor (MRG) Market Concentration Ratio (CR5 and HHI)
3.2 Metabotropic Glutamate Receptor (MRG) Revenue by Manufacturers
3.2.1 Metabotropic Glutamate Receptor (MRG) Revenue by Manufacturers (2014-2019)
3.2.2 Metabotropic Glutamate Receptor (MRG) Revenue Share by Manufacturers (2014-2019)
3.3 Metabotropic Glutamate Receptor (MRG) Price by Manufacturers
3.4 Metabotropic Glutamate Receptor (MRG) Manufacturing Base Distribution, Product Types
3.4.1 Metabotropic Glutamate Receptor (MRG) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Metabotropic Glutamate Receptor (MRG) Product Type
3.4.3 Date of International Manufacturers Enter into Metabotropic Glutamate Receptor (MRG) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Metabotropic Glutamate Receptor (MRG) Sales by Product
4.2 Global Metabotropic Glutamate Receptor (MRG) Revenue by Product
4.3 Metabotropic Glutamate Receptor (MRG) Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Metabotropic Glutamate Receptor (MRG) Breakdown Data by End User

6 North America
6.1 North America Metabotropic Glutamate Receptor (MRG) by Countries
6.1.1 North America Metabotropic Glutamate Receptor (MRG) Sales by Countries
6.1.2 North America Metabotropic Glutamate Receptor (MRG) Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Metabotropic Glutamate Receptor (MRG) by Product
6.3 North America Metabotropic Glutamate Receptor (MRG) by End User

7 Europe
7.1 Europe Metabotropic Glutamate Receptor (MRG) by Countries
7.1.1 Europe Metabotropic Glutamate Receptor (MRG) Sales by Countries
7.1.2 Europe Metabotropic Glutamate Receptor (MRG) Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Metabotropic Glutamate Receptor (MRG) by Product
7.3 Europe Metabotropic Glutamate Receptor (MRG) by End User

8 Asia Pacific
8.1 Asia Pacific Metabotropic Glutamate Receptor (MRG) by Countries
8.1.1 Asia Pacific Metabotropic Glutamate Receptor (MRG) Sales by Countries
8.1.2 Asia Pacific Metabotropic Glutamate Receptor (MRG) Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Metabotropic Glutamate Receptor (MRG) by Product
8.3 Asia Pacific Metabotropic Glutamate Receptor (MRG) by End User

9 Central & South America
9.1 Central & South America Metabotropic Glutamate Receptor (MRG) by Countries
9.1.1 Central & South America Metabotropic Glutamate Receptor (MRG) Sales by Countries
9.1.2 Central & South America Metabotropic Glutamate Receptor (MRG) Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Metabotropic Glutamate Receptor (MRG) by Product
9.3 Central & South America Metabotropic Glutamate Receptor (MRG) by End User

10 Middle East and Africa
10.1 Middle East and Africa Metabotropic Glutamate Receptor (MRG) by Countries
10.1.1 Middle East and Africa Metabotropic Glutamate Receptor (MRG) Sales by Countries
10.1.2 Middle East and Africa Metabotropic Glutamate Receptor (MRG) Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Metabotropic Glutamate Receptor (MRG) by Product
10.3 Middle East and Africa Metabotropic Glutamate Receptor (MRG) by End User

11 Company Profiles
11.1 Addex Therapeutics (Switzerland)
11.1.1 Addex Therapeutics (Switzerland) Company Details
11.1.2 Company Business Overview
11.1.3 Addex Therapeutics (Switzerland) Metabotropic Glutamate Receptor (MRG) Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Addex Therapeutics (Switzerland) Metabotropic Glutamate Receptor (MRG) Products Offered
11.1.5 Addex Therapeutics (Switzerland) Recent Development
11.2 Domain Therapeutics (France)
11.2.1 Domain Therapeutics (France) Company Details
11.2.2 Company Business Overview
11.2.3 Domain Therapeutics (France) Metabotropic Glutamate Receptor (MRG) Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Domain Therapeutics (France) Metabotropic Glutamate Receptor (MRG) Products Offered
11.2.5 Domain Therapeutics (France) Recent Development
11.3 Medgenics (USA)
11.3.1 Medgenics (USA) Company Details
11.3.2 Company Business Overview
11.3.3 Medgenics (USA) Metabotropic Glutamate Receptor (MRG) Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Medgenics (USA) Metabotropic Glutamate Receptor (MRG) Products Offered
11.3.5 Medgenics (USA) Recent Development
11.4 Prexton Therapeutics (Switzerland)
11.4.1 Prexton Therapeutics (Switzerland) Company Details
11.4.2 Company Business Overview
11.4.3 Prexton Therapeutics (Switzerland) Metabotropic Glutamate Receptor (MRG) Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Prexton Therapeutics (Switzerland) Metabotropic Glutamate Receptor (MRG) Products Offered
11.4.5 Prexton Therapeutics (Switzerland) Recent Development
11.5 Taisho Pharmaceutical Holding (Japan)
11.5.1 Taisho Pharmaceutical Holding (Japan) Company Details
11.5.2 Company Business Overview
11.5.3 Taisho Pharmaceutical Holding (Japan) Metabotropic Glutamate Receptor (MRG) Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Taisho Pharmaceutical Holding (Japan) Metabotropic Glutamate Receptor (MRG) Products Offered
11.5.5 Taisho Pharmaceutical Holding (Japan) Recent Development

12 Future Forecast
12.1 Metabotropic Glutamate Receptor (MRG) Market Forecast by Regions
12.1.1 Global Metabotropic Glutamate Receptor (MRG) Sales Forecast by Regions 2019-2025
12.1.2 Global Metabotropic Glutamate Receptor (MRG) Revenue Forecast by Regions 2019-2025
12.2 Metabotropic Glutamate Receptor (MRG) Market Forecast by Product
12.2.1 Global Metabotropic Glutamate Receptor (MRG) Sales Forecast by Product 2019-2025
12.2.2 Global Metabotropic Glutamate Receptor (MRG) Revenue Forecast by Product 2019-2025
12.3 Metabotropic Glutamate Receptor (MRG) Market Forecast by End User
12.4 North America Metabotropic Glutamate Receptor (MRG) Forecast
12.5 Europe Metabotropic Glutamate Receptor (MRG) Forecast
12.6 Asia Pacific Metabotropic Glutamate Receptor (MRG) Forecast
12.7 Central & South America Metabotropic Glutamate Receptor (MRG) Forecast
12.8 Middle East and Africa Metabotropic Glutamate Receptor (MRG) Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Metabotropic Glutamate Receptor (MRG) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer